Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy

被引:25
作者
Lachmann, Nils [1 ]
Schoenemann, Constanze [1 ]
El-Awar, Nadim [2 ]
Everly, Matthew [3 ]
Budde, Klemens [4 ]
Terasaki, Paul I. [3 ]
Waiser, Johannes [4 ]
机构
[1] Charite Univ Med Berlin, Ctr Tumor Med, Tissue Typing Lab, Berlin, Germany
[2] One Lambda Inc, Canoga Pk, CA USA
[3] Terasaki Fdn, Los Angeles, CA USA
[4] Charite Univ Med Berlin, Dept Internal Med Nephrol, Charite Campus Mitte, Berlin, Germany
关键词
allograft nephrectomy; epitope; HLA antibodies; renal transplantation; DONOR-SPECIFIC ANTIBODIES; HLA ANTIBODIES; KIDNEY-TRANSPLANT; GRAFT-SURVIVAL; FLOW-CYTOMETRY; FAILURE; IMMUNOSUPPRESSION; ALLOANTIBODY; NEPHROPATHY; MANAGEMENT;
D O I
10.1093/ndt/gfw041
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
A considerable proportion of patients awaiting kidney transplantation is immunized by previous transplantation(s). We investigated how allograft nephrectomy (Nx) and withdrawal of maintenance immunosuppression (WD-MIS) in patients with a failed renal allograft contribute to allosensitization. HLA antibodies (HLAabs) were analyzed before and after Nx and/or WD-MIS using a single antigen bead assay. Patients were grouped as follows: (A) Nx and concomitant WD-MIS (n = 28), (B) Nx (n = 14) and (C) WD-MIS (n = 12). In a subgroup of patients, the epitope specificity of HLAabs was determined by adsorption and elution of sera with recombinant single HLA allele-expressing cell lines. Following Nx and/or WD-MIS, HLAabs were detectable in 100, 100 and 92% of patients in Groups A, B and C, respectively. In patients of all groups, de novo donor-specific HLAabs (DSAs) were found. After Nx, an increase in the breadth [percent panel reactive antibody (%PRA)] and mean fluorescence intensity of class I HLAabs was predominant. In contrast, an increase of class II HLAabs prevailed following WD-MIS. Experimental analysis of the epitope specificities revealed that 64% of the class I HLAabs classically denoted as non-DSA were donor epitope-specific HLAabs (DESA). Both Nx and WD-MIS contribute to alloimmunization with differing patterns concerning class I and II HLAabs. Nx preferentially increased class I HLAabs and most of the observed class I HLAabs were DESA. Considering that class I, but not class II, HLA molecules are constitutively expressed, our results support the hypothesis that the increase of HLAabs following Nx might have been caused by removal of the adsorbing donor tissue (sponge hypothesis).
引用
收藏
页码:1351 / 1359
页数:9
相关论文
共 33 条
  • [1] European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care
    Abramowicz, Daniel
    Cochat, Pierre
    Claas, Frans H. J.
    Heemann, Uwe
    Pascual, Julio
    Dudley, C.
    Harden, Paul
    Hourmant, Marivonne
    Maggiore, Umberto
    Salvadori, Maurizio
    Spasovski, Goce
    Squifflet, Jean-Paul
    Steiger, Juerg
    Torres, Armando
    Viklicky, Ondrej
    Zeier, Martin
    Vanholder, Raymond
    Van Biesen, Wim
    Nagler, Evi
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (11) : 1790 - 1797
  • [2] Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches
    Adeyi, OA
    Girnita, AL
    Howe, J
    Marrari, M
    Awadalla, Y
    Askar, M
    Martell, J
    Zeevi, A
    Shapiro, R
    Nalesnik, M
    Randhawa, P
    Demetris, AJ
    Duquesnoy, RJ
    [J]. TRANSPLANT IMMUNOLOGY, 2005, 14 (01) : 53 - 62
  • [3] Summary of the British Transplantation Society Guidelines for Management of the Failing Kidney Transplant
    Andrews, Peter A.
    [J]. TRANSPLANTATION, 2014, 98 (11) : 1130 - 1133
  • [4] Independent of Nephrectomy, Weaning Immunosuppression Leads to Late Sensitization After Kidney Transplant Failure
    Augustine, Joshua J.
    Woodside, Kenneth J.
    Padiyar, Aparna
    Sanchez, Edmund Q.
    Hricik, Donald E.
    Schulak, James A.
    [J]. TRANSPLANTATION, 2012, 94 (07) : 738 - 743
  • [5] Transplant Nephrectomy Improves Survival following a Failed Renal Allograft
    Ayus, Juan Carlos
    Achinger, Steven G.
    Lee, Shuko
    Sayegh, Mohamed H.
    Go, Alan S.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (02): : 374 - 380
  • [6] Kidney Intragraft Donor-Specific Antibodies as Determinant of Antibody-Mediated Lesions and Poor Graft Outcome
    Bachelet, T.
    Couzi, L.
    Lepreux, S.
    Legeret, M.
    Pariscoat, G.
    Guidicelli, G.
    Merville, P.
    Taupin, J-L
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (11) : 2855 - 2864
  • [7] Immunosuppression after renal allograft failure: a survey of US practices
    Bayliss, George P.
    Gohh, Reginald Y.
    Morrissey, Paul E.
    Rodrigue, James R.
    Mandelbrot, Didier A.
    [J]. CLINICAL TRANSPLANTATION, 2013, 27 (06) : 895 - 900
  • [8] The failed renal transplant: In or out?
    Bennett, WM
    [J]. SEMINARS IN DIALYSIS, 2005, 18 (03) : 188 - 189
  • [9] Donor-Directed HLA Antibodies Before and After Transplantectomy Detected by the Luminex Single Antigen Assay
    Billen, Evy V. A.
    Christiaans, Maarten H. L.
    Lee, JarHow
    van den Berg-Loonen, Ella M.
    [J]. TRANSPLANTATION, 2009, 87 (04) : 563 - 569
  • [10] Maintaining immunosuppressive treatment after early allograft nephrectomy does not reduce the risk of anti-HLA allosensitization
    Del Bello, Arnaud
    Congy-Jolivet, Nicolas
    Kamar, Nassim
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 (09) : 1113 - 1115